Physician

Christopher Thomas Yingling, MD

According to 2025 Medicare claims, Christopher Yingling, MD (NPI: 1912153503) practices urology in the State College, PA market, with the plurality of this provider's patient population coming from Centre, PA. This provider's primary affiliated billing organization is MOUNT NITTANY MEDICAL CENTER HEALTH SERVICES INC (NPI: 1598992554; TIN: 510426500) and primary practice location at 16803-2106. Yingling is affiliated with the Keystone ACO (ACO ID: A1552) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Yingling's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 561 traditional Medicare patients, billed 2,656 HCPCS/CPT codes, and received $131,803 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,838 prescription claims across 589 beneficiaries totaling $799,045 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 17 claims. Open Payments data shows 74 records totaling $1,348. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $67,490 to $799,045. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	374	1,943	$127,027
2016	467	2,468	$121,099
2017	525	2,429	$135,777
2018	607	2,792	$132,010
2019	619	2,513	$130,870
2020	587	3,919	$135,837
2021	568	3,656	$146,292
2022	555	3,966	$180,913
2023	508	4,154	$126,877
2024	561	2,656	$131,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	212	745	$67,490
2016	302	1,083	$86,429
2017	383	1,298	$108,692
2018	443	1,627	$145,984
2019	472	1,932	$182,956
2020	446	1,592	$200,557
2021	462	1,462	$424,507
2022	439	1,335	$510,343
2023	454	1,339	$288,998
2024	589	1,838	$799,045

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$2,733
2020	N/R	11	$3,312
2021	N/R	46	$14,778
2022	N/R	22	$3,631
2023	N/R	17	$927
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	93	108	$163
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	32	32	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	281	356	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	187	213	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	94	95	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	46	1,380	$666,678
Gemtesa	Vibegron	41	2,440	$36,701
Myrbetriq	Mirabegron	37	2,370	$33,952
Tamsulosin Hcl	Tamsulosin Hcl	649	45,484	$12,145
Dutasteride	Dutasteride	136	11,386	$7,807

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$1,348	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Thomas Yingling, MD?

Tedicare shows public-source Medicare data for Christopher Thomas Yingling, MD (NPI 1912153503), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Thomas Yingling, MD have ACO affiliation data?

Christopher Thomas Yingling, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Christopher Thomas Yingling, MD?

Christopher Thomas Yingling, MD is linked to MOUNT NITTANY MEDICAL CENTER HEALTH SERVICES INC (billing NPI 1598992554) in the available physician profile data.

Does Christopher Thomas Yingling, MD have Open Payments data?

Christopher Thomas Yingling, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.